Arax Advisory Partners’s HUTCHMED HCM Stock Holding History

Arax Advisory Partners’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54K	Hold	103	–	–	﹤0.01%	3182
2025 Q4	$1.37K	Sell	103 -103	-50%	-$1.5K	﹤0.01%	3399
2025 Q3	$3.25K	Buy	206 +103	+100%	+$1.7K	﹤0.01%	2993
2025 Q2	$1.55K	Hold	103	–	–	﹤0.01%	2648
2025 Q1	$1.55K	Hold	103	–	–	﹤0.01%	2153
2024 Q4	$1.49K	Hold	103	–	–	﹤0.01%	2080
2024 Q3	$2.01K	Hold	103	–	–	﹤0.01%	2065
2024 Q2	$1.76K	Hold	103	–	–	﹤0.01%	2010
2024 Q1	$1.73K	Hold	103	–	–	﹤0.01%	1060
2023 Q4	$1.87K	Hold	103	–	–	﹤0.01%	1029
2023 Q3	$1.75K	Hold	103	–	–	﹤0.01%	1037
2023 Q2	$1.24K	Hold	103	–	–	﹤0.01%	1076
2023 Q1	$1.34K	Hold	103	–	–	﹤0.01%	1051
2022 Q4	$1.52K	Hold	103	–	–	﹤0.01%	986
2022 Q3	$1K	Sell	103 -15	-13%	-$189	﹤0.01%	1082
2022 Q2	$1K	Buy	118 +60	+103%	+$764	﹤0.01%	1050
2022 Q1	$1K	Buy	58 +22	+61%	+$560	﹤0.01%	1037
2021 Q4	$1K	Buy	36 +21	+140%	+$682	﹤0.01%	1017
2021 Q3	$1K	Buy	+15	New	+$590	﹤0.01%	908

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Arax Advisory Partners's HCM Position: Q1 2026 in Review

Arax Advisory Partners held its HUTCHMED (HCM) position steady in Q1 2026 at 103 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3182.

Arax Advisory Partners first reported a position in HCM in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.25K in Q3 2025. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

Arax Advisory Partners held 103 shares of HUTCHMED worth $1.54K as of Q1 2026.
Arax Advisory Partners left its HUTCHMED share count unchanged in Q1 2026.
HUTCHMED made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3182 holding.
Arax Advisory Partners first reported a position in HUTCHMED in Q3 2021 and has held it in 19 quarters since.
Arax Advisory Partners's HUTCHMED position peaked at $3.25K in Q3 2025.
54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.